These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Treatment of invasive fungal infections in immunocompromised patients with fluconazole. Esposito R; Uberti Foppa C; Cernuschi M J Chemother; 1989 Jul; 1(4 Suppl):925-6. PubMed ID: 16312707 [No Abstract] [Full Text] [Related]
5. Fluconazole prophylaxis for critically ill patients at high risk for Candida infection. Garbino J Clin Infect Dis; 2005 Dec; 41(11):1690-1. PubMed ID: 16267753 [No Abstract] [Full Text] [Related]
6. Inadequate proof of adverse outcome due to the use of fluconazole in critically ill patients. Blot SI; Hoste EA; Vandewoude KH; Colardyn FA Arch Surg; 2000 Sep; 135(9):1114. PubMed ID: 10982521 [No Abstract] [Full Text] [Related]
7. Cost-effectiveness analysis of micafungin versus fluconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplantation in Korea. Sohn HS; Lee TJ; Kim J; Kim D Clin Ther; 2009 May; 31(5):1105-15; discussion 1066-8. PubMed ID: 19539111 [TBL] [Abstract][Full Text] [Related]
8. Comparison between fluconazole and ketoconazole effectivity in the treatment of pityriasis versicolor. Yazdanpanah MJ; Azizi H; Suizi B Mycoses; 2007 Jul; 50(4):311-3. PubMed ID: 17576325 [TBL] [Abstract][Full Text] [Related]
9. In meta-analysis itraconazole is superior to fluconazole for prophylaxis of systemic fungal infection in the treatment of haematological malignancy. Prentice AG; Glasmacher A; Djulbegovic B Br J Haematol; 2006 Mar; 132(5):656-8; author reply 658-9. PubMed ID: 16445845 [No Abstract] [Full Text] [Related]
10. What does preemptive antifungal treatment really mean? Stefani PM; Salvadori U; Gottardi M; Rigoli R; Scotton P; Gherlinzoni F Clin Infect Dis; 2010 Apr; 50(8):1201-2; author reply 1202. PubMed ID: 20233047 [No Abstract] [Full Text] [Related]
11. [Hospital Universitario La Fe Guide to the prophylaxis and treatment of fungal infections in immunodepressed patients or in patients requiring special care]. Jarque I; Salavert M; Romá E; Gobernado M; Chiveli MA; Ruano M; Solé A; Poveda JL; Ferrer E; García-Pellicer J; Sanz MA; Pemán J; Sánchez V; Rev Esp Quimioter; 2004 Dec; 17(4):357-89. PubMed ID: 15696227 [No Abstract] [Full Text] [Related]
12. Current practice of antifungal prophylaxis and treatment in immunocompromised children and adults with malignancies: a single centre approach. Lehrnbecher T; Mousset S; Sörensen J; Böhme A Mycoses; 2009 Mar; 52(2):107-17. PubMed ID: 18983431 [TBL] [Abstract][Full Text] [Related]
13. Fungal prophylaxis in very low birth weight neonates: nystatin, fluconazole or nothing? Isaacs D Curr Opin Infect Dis; 2008 Jun; 21(3):246-50. PubMed ID: 18448968 [TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness analysis of antifungal prophylaxis in patients undergoing hematopoietic stem cell transplantation. Schonfeld W; Wang Cheng J; Tong KB; Seifeldin R Clin Ther; 2008 May; 30(5):964-73. PubMed ID: 18555943 [TBL] [Abstract][Full Text] [Related]